Jpmorgan Chase & CO Rx Sight, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RXST
# of Institutions
227Shares Held
31.3MCall Options Held
57.8KPut Options Held
12.5K-
Ra Capital Management, L.P. Boston, MA3.69MShares$189 Million3.35% of portfolio
-
Black Rock Inc. New York, NY2.4MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$103 Million0.0% of portfolio
-
Lord, Abbett & Co. LLC Jersey City, NJ1.74MShares$88.9 Million0.34% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI1.33MShares$68.4 Million0.13% of portfolio
About RxSight, Inc.
- Ticker RXST
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 27,638,900
- Market Cap $1.42B
- Description
- RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...